The adjuvant use of plasma rich in growth factors in the inferior alveolar nerve repositioning technique.

PURPOSE

To describe the outcomes of the adjuvant use of plasma rich in growth factors (PRGF) in the inferior alveolar nerve repositioning surgery.

MATERIAL AND METHODS

A retrospective report of three cases was conducted in a single private dental clinic. The variables were the residual alveolar bone height, the surgical complications, the occurrence of neurosensory complications, the marginal bone stability and the implant survival. A descriptive statistical analysis was performed.

RESULTS

Three inferior alveolar repositioning were performed with the adjuvant use of PRGF. The residual alveolar bone height was 2.2 ± 0.14 mm. All patients underwent uneventful healing with no symptoms of neurosensory complications neither implant failure. The marginal bone loss was 0.1 ± 0.4 mm.

CONCLUSIONS

The preventative and adjuvant use of PRGF in inferior alveolar nerve repositioning need to be assessed in prospective studies with a larger sample size.